Evidence map›Paper›PMID 40416268›Full record

ArticleCureus2025

Macrophage Activation Syndrome Revealing Hodgkin Lymphoma: A Pediatric Case Report.

Ahmed Hared Bouh, Omar Moussa Sougueh, Amal Miqdadi, Inssaf Al Ammari, Nouzha Dini

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ahmed Hared BouhPediatrics, Mohammed VI International University Hospital, Mohammed VI University of Sciences and Health-UM6SS, Casablanca, MAR.
Omar Moussa SouguehPediatrics, Mohammed VI International University Hospital, Mohammed VI University of Sciences and Health-UM6SS, Casablanca, MAR.
Amal MiqdadiNuclear Medicine, Mohammed VI International University Hospital, Mohammed VI University of Sciences and Health-UM6SS, Casablanca, MAR.
Inssaf Al AmmariPediatrics, Mohammed VI International University Hospital, Mohammed VI University of Sciences and Health-UM6SS, Casablanca, MAR.
Nouzha DiniPediatrics, Mohammed VI International University Hospital, Mohammed VI University of Sciences and Health-UM6SS, Casablanca, MAR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Secondary macrophage activation syndrome is a severe and rare complication of infectious, autoimmune, and malignant diseases. Herein, we report the case of a 10-year-old child with this syndrome leading to the discovery of Hodgkin lymphoma. The patient, who had a medical history of cerebral palsy and ataxia-telangiectasia syndrome, was admitted for prolonged fever associated with cough, which had evolved into general health deterioration for two months prior to admission. He received multiple courses of antibiotic therapy for suspected pneumonia without clinical improvement. Clinical examination showed pallor, deteriorated general condition, high fever, asthenia, cervical adenopathy, and splenomegaly. The clinical and biological criteria led to the diagnosis of macrophage activation syndrome. Lymph node histology confirmed the diagnosis of Hodgkin lymphoma, which was staged as stage IV via positron emission tomography scan. The "vincristine, etoposide, prednisone, and doxorubicin" (OEPA) chemotherapy regimen was initiated, followed by the "cyclophosphamide, vincristine, prednisone, and dacarbazine" (COPDAC) regimen, with remission achieved both clinically and paraclinically after one cycle of each regimen.

Indexed as

adenopathyfeverhistologyhodgkin lymphomamacrophage activation syndrome

Identifiers

PMID40416268
PMCPMC12103714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.